Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: Results from the BONE study

P. D. Delmas, R. R. Recker, C. H. Chesnut, A. Skag, J. A. Stakkestad, R. Emkey, J. Gilbride, R. C. Schimmer, C. Christiansen

Research output: Contribution to journalArticlepeer-review

243 Scopus citations

Fingerprint

Dive into the research topics of 'Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: Results from the BONE study'. Together they form a unique fingerprint.

Medicine & Life Sciences